In trading on Thursday, the SPDR S&P Biotech ETF (AMEX:XBI) is outperforming other ETFs, up about 3.9% on the day. Components of that ETF showing particular strength include shares of Acadia Pharmaceuticals (NASDAQ:ACAD), up about 13.8% and shares of Celldex Therapeutics (NASDAQ:CLDX), up about 10.6% on the day.
And underperforming other ETFs today is the iShares U.S. Preferred Stock ETF (AMEX:PFF), up about 0.3% in Thursday afternoon trading. Among components of that ETF with the weakest showing on Thursday were shares of Office Properties Trust Series L shares (NYSE:OFC.PRL), lower by about 1.6%, and shares of Taubman Centers Series J shares (NYSE:TCO.PRJ), lower by about 0.9% on the day.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.